Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Palliative Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hardy, J.
Right arrow Articles by Hanks, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hardy, J.
Right arrow Articles by Hanks, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Pitfalls in placebo-controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstruction

Janet Hardy

Julie Ling

Janine Mansi

Richard Isaacs

Department of Palliative Medicine, Royal Marsden NHS Trust, London

Judith Bliss

Roger A'Hern

Peter Blake

Martin Gore

John Shepherd

Royal Marsden NHS Trust, London and Surrey

Geoff Hanks

To determine the effect of dexamethasone when treating malignant bowel obstruction, 35 patients were randomized to receive intravenous dexamethasone or a placebo, crossing over to the alternate treatment arm if there had been no resolution of obstruction by day 5. This was done in two consecutive studies. Patients were stratified according to whether or not they had received specific anticancer therapy within 28 days of study. In trial 1, 15 out of 22 patients ‘responded’ (resolution of obstruction by day 5; 10 on dexamethasone, five on placebo). Eleven out of 15 patients were ‘on treatment’. In trial 2, six out of 13 responded (three on dexamethasone, three on placebo); three out of six were ‘on treatment’. When both studies are combined, 60% (21/35) patients responded (13 on dexamethasone, eight on placebo). Poor patient accrual terminated both studies. Numbers are too small to allow a combination of studies or formal statistical analysis. We are unable to make any conclusion as to the effectiveness of dexamethasone in the palliation of malignant bowel disease.

Key Words: controlled clinical trials • dexamethasone • intestinal obstruction • palliative care

Palliative Medicine, Vol. 12, No. 6, 437-442 (1998)
DOI: 10.1191/026921698666334766


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
JCOHome page
A. Naeim, S. M. Dy, K. A. Lorenz, H. Sanati, A. Walling, and S. M. Asch
Evidence-Based Recommendations for Cancer Nausea and Vomiting
J. Clin. Oncol., August 10, 2008; 26(23): 3903 - 3910.
[Abstract] [Full Text] [PDF]


Home page
Nurs EthicsHome page
K. Arraf, G. Cox, and K. Oberle
Using the Canadian Code Of Ethics for Registered Nurses to Explore Ethics in Palliative Care Research
Nursing Ethics, November 1, 2004; 11(6): 600 - 609.
[Abstract] [PDF]


Home page
Palliat MedHome page
P. Edmonds and C. Lucas
A trial that failed because of poor recruitment
Palliative Medicine, September 1, 2003; 17(6): 557 - 557.
[PDF]


Home page
Palliat MedHome page
G Laval, J Girardier, J M Lassauniere, B Leduc, C Haond, and R Schaerer
The use of steroids in the management of inoperable intestinal obstruction in terminal cancer patients: do they remove the obstruction?
Palliative Medicine, January 1, 2000; 14(1): 3 - 10.
[Abstract] [PDF]